Manufacturing Innovation

Manufacturing Innovation

  • Innovation in upstream & downstream manufacturing of prophylactic and therapeutic vaccines
  • Automated manufacturing of diverse vaccine platforms, from protein to viral vector
  • Progress in synthetic (plasmid-free) manufacturing of RNA
  • Reducing wastage and improving sustainability of single-use systems
  • Overcoming bottlenecks in continuous manufacturing e.g.,  continuous ultra/diafiltration, single-pass tangential flow filtration (SPTFF), fixed bed bioreactors
  • Bringing down the high costs of GMP facilities and raw materials
  • Cell-free systems for production of recombinant protein vaccines
  • Next-gen purification equipment, including new chromatography chemistries and columns, to lower impurities and increase yield
  • Advanced tools to effectively manage the supply chain

 

}